Survival analysis of completely resected stage III B non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 10, Issue 2, 2007, Pages 107-110

  Wei, Weidong ^a   Wang, Siyu ^a   Lin, Peng ^a   Li, Xiaodong ^a   Wen, Zhesheng ^a   Rong, Tiehua ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Carcinoma; Lung neoplasm; Non small cell lung; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDY;

EID: 34247543059     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. National Comprehensive Cancer Network. Clinical practice guidelines in oncology_v. 2. 2006. Non-small cell lung cancer. http:// www.nccn.org/ professionals/physician.gls/PDF/nscl.pdf
2. Trodella L, De Marinis F, D'Angelillo RM, et al. Induction cisplatin-gemcitabine-paclitaxel plus concurrent radiotherapy and gemcitabine in the multimodality treatment of unresectable stage III B non-small cell lung cancer. Lung Cancer,2006,54(3):331-338.
3. Fang DK(CfrSIt), Zhang DW, Huang GJ, et al. Results of surgical resection of patients with primary lung cancer: a retrospective analysis of 1905 cases. Ann Thorac Surg,2001,72(4):1155-1159.
4. Liu SK, Xu SF, Luo BJ, et al. Multivariate analysis of prognosis in 1380 patients with non-small cell lung cancer following surgical procedure. Chin J Lung Cancer,2006,9(5):465-468.
5. Goya T, Asamura H, Yoshimura H, et al. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. Lung Cancer,2005,50(2):227-234.
6. Peng ZM, Chen JH, Meng L, et al. Resection for lung cancer invading the superior vena cava. Chin J Surg,2006,44(6):402-404.
7. Ichinose Y, Fukuyama Y, Asoh H, et al. Induction chemoradiotherapy and surgical resection for selected stage III B non-small-cell lung cancer. Ann Thorac Surg,2003,76(6):1810-1815.
8. Nakagawa T, Okumura N, Miyoshi K, et al. Prognostic factors in patients with ipsilateral pulmonary metastasis from non-small cell lung cancer. Eur J Cardiothorac Surg,2005,28(4):635-639.
9. Xin Y, Han BH. Prognosis of ipsilateral intrapulmonary metastasis in resected non-small cell lung cancer. TUMOR,2005,25(4):393-395.
10. Bryant AS, Pereira SJ, Miller DL, et al. Satellite pulmonary nodule in the same lobe (T4N0) should not be staged as III B non-small cell lung cancer. Ann Thorac Surg,2006,82(5):1808-1814.
11. Douillard JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage I B-III A non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol,2006,7(9):719- 727. Erratum in: Lancet Oncol,2006,7(10):797.
12. Comment in: Lancet Oncol, 2006,7(9):701-703.
13. Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med,2005,352(25):2589-2597.
14. Comment in: N Engl J Med, 2005,352(25):2640-2642;
15. 2005,353(14):1523-1524.
16. Kato H, Ichinose Y, Ohta M, et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med,2004,350(17):1713-1721.
17. Commentin: Cancer Treat Rev,2004,30(7):661-664;
18. N Engl J Med,2004,350 (17):1777-1779;
19. N Engl J Med,2004,351(7):713-714; author reply 713-714.
20. Barlesi F, Doddoli C, Torre JP, et al. Comparative prognostic features of stage III AN2 and III B non-small-cell lung cancer patients treated with surgery after induction therapy. Eur J Cardiothorac Surg,2005,28(4):629-634.
21. Takeda S, Maeda H, Okada T, et al. Results of pulmonary resection following neoadjuvant therapy for locally advanced (III A-III B) lung cancer. Eur J Cardiothorac Surg,2006,30(1):184-189.
22. Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science, 2004,304(5676):1497-1500.
23. Comment in: Adv Anat Pathol, 2005,12(2):47-52;
24. Science,2004,304(5676):1458-1461.